急性冠脉综合征抗血小板和抗凝药物应用进展  

Advancements in Antiplatelet and Anticoagulant Therapy for Acute Coronary Syndrome

作　　者：张佳兴 李飞[1] ZHANG Jiaxing;LI Fei(The First Affiliated Hospital of Yangtze University Emergency Department,Jingzhou 434000,China)

机构地区：[1]长江大学附属第一医院急诊科,湖北荆州434000

出　　处：《中华灾害救援医学》2024年第7期813-817,共5页Chinese Journal of Disaster Medicine

摘　　要：急性冠脉综合征(ACS)是心血管疾病中常见的临床表现,其治疗中抗血小板和抗凝药物的应用至关重要。近年来,研究强调了双重抗血小板疗法(DAPT)与新型口服抗凝药物(NOACs)的联合使用,以改善患者预后。最新进展表明,个体化治疗策略能够显著减少心血管事件的发生率,同时降低出血风险。本文将对ACS急救抗血小板和抗凝药物的应用进展进行综述,旨在为临床医生提供最新的治疗指南和参考。Acute Coronary Syndrome(ACS)is a common clinical manifestation of cardiovascular diseases,where the application of antiplatelet and anticoagulant drugs plays a crucial role in its treatment.Recent studies have highlighted the importance of combining dual antiplatelet therapy(DAPT)with novel oral anticoagulants(NOACs)to improve patient outcomes.The latest advancements indicate that personalized treatment strategies can significantly reduce the incidence of cardiovascular events while minimizing the risk of bleeding.This paper will review the advancements in the application of antiplatelet and anticoagulant drugs in the emergency treatment of Acute Coronary Syndrome(ACS),aiming to provide clinicians with the latest treatment guidelines and references.

关 键 词：心血管疾病 急救医学 综述 

分 类 号：R459.7[医药卫生—急诊医学]